The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Open accessAbstract
Background Patients with COVID-19 who have underlying malignancy have a higher mortality rate compared with those without cancer, although the magnitude of such excess risk is not clearly defined. We performed a systematic review and pooled analysis to provide precise estimates of the mortality rate among patients with both cancer and COVID-19. Methods A systematic literature search involving peer reviewed publications, preprints, and conference proceedings up to July 16, 2020 was performed. The primary endpoint was the case fatality rate (CFR), defined as rate of death among patients with cancer and COVID-19. The CFR was assessed with a random effects model, which was used to derive a pooled CFR and its 95% confidence interval (CI). Results 52 studies, involving a total of 18,650 patients with both COVID-19 and cancer were selected for the pooled analysis. A total of 4,243 deaths were recorded in this population. The probability of death was 25·6% (95% CI 22·0% to 29·9%; I2=48·9%) in this patient population. Conclusions Patients with cancer who develop COVID-19 have high probability of mortality. Appropriate and aggressive preventive measures must be taken to reduce the risk of COVID-19 in patients with cancer, and to optimally manage those who do contract the infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31187-9 · Cited by 1,726
Nepogodiev, D., Bhangu, A., Glasbey, J. C., Li, E., Omar, O. M., Simoes, J. F., Abbott, T. E., Alser, O., Arnaud, A. P., Bankhead-Kendall, B. K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31182-x · Cited by 1,711
Grasselli, G., Greco, M., Zanella, A., Albano, G., Antonelli, M., Bellani, G., Bonanomi, E., Cabrini, L., Carlesso, E., Castelli, G., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.3539 · Cited by 1,612
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0422 · Cited by 1,589
Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R., Jia, P., Guan, H. Q., Peng, L., Chen, Y., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.296 · Cited by 1,498
Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J., & Jiang, H. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.019 · Cited by 1,175
Lee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31173-9 · Cited by 1,103
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0980 · Cited by 1,071
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
Gupta, S., Hayek, S. S., Wang, W., Chan, L., Mathews, K. S., Melamed, M. L., Brenner, S. K., Leonberg-Yoo, A., Schenck, E. J., Radbel, J., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.3596 · Cited by 957
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0516 · Cited by 765
Suleyman, G., Fadel, R. A., Malette, K. M., Hammond, C., Abdulla, H., Entz, A., Demertzis, Z., Hanna, Z., Failla, A., Dagher, C., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.12270 · Cited by 695
Determinants of COVID-19 disease severity in patients with cancer
Robilotti, E. V., Babady, N. E., Mead, P. A., Rolling, T., Perez-Johnston, R., Bernardes, M., Bogler, Y., Caldararo, M., Figueroa, C. J., Glickman, M. S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0979-0 · Cited by 628
Garassino, M. C., Whisenant, J. G., Huang, L.-C., Trama, A., Torri, V., Agustoni, F., Baena, J., Banna, G., Berardi, R., Bettini, A. C., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30314-4 · Cited by 612
Yang, K., Sheng, Y., Huang, C., Jin, Y., Xiong, N., Jiang, K., Lu, H., Liu, J., Yang, J., Dong, Y., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30310-7 · Cited by 584
Tian, J., Yuan, X., Xiao, J., Zhong, Q., Yang, C., Liu, B., Cai, Y., Lu, Z., Wang, J., Wang, Y., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30309-0 · Cited by 528
Montopoli, M., Zumerle, S., Vettor, R., Rugge, M., Zorzi, M., Catapano, C. V., Carbone, G. M., Cavalli, A., Pagano, F., Ragazzi, E., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.479 · Cited by 518
COVID-19 in persons with haematological cancers
He, W., Chen, L., Chen, L., Yuan, G., Fang, Y., Chen, W., Wu, D., Liang, B., Lu, X., Ma, Y., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0836-7 · Cited by 462
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., Katsoulis, M., Williams, B., Pillay, D., Noursadeghi, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-043828 · Cited by 447
Sharpless, N. E. (2020) · Science · doi:10.1126/science.abd3377 · Cited by 408
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
Miyashita, H., Mikami, T., Chopra, N., Yamada, T., Chernyavsky, S., Rizk, D., & Cruz, C. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.006 · Cited by 379
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
Ciceri, F., Castagna, A., Rovere-Querini, P., De Cobelli, F., Ruggeri, A., Galli, L., Conte, C., De Lorenzo, R., Poli, A., Ambrosio, A., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108509 · Cited by 293
COVID-19 in patients with lung cancer
Luo, J., Rizvi, H., Preeshagul, I. R., Egger, J. V., Hoyos, D., Bandlamudi, C., McCarthy, C. G., Falcon, C. J., Schoenfeld, A. J., Arbour, K. C., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.007 · Cited by 267
Scarfò, L., Chatzikonstantinou, T., Rigolin, G. M., Quaresmini, G., Motta, M., Vitale, C., Garcia-Marco, J. A., Hernández-Rivas, J. Á., Mirás, F., Baile, M., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0959-x · Cited by 264
Clinical determinants for fatality of 44,672 patients with COVID-19
Deng, G., Yin, M., Chen, X., & Zeng, F. (2020) · Critical Care · doi:10.1186/s13054-020-02902-w · Cited by 251
Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies
Martín‐Moro, F., Marquet, J., Piris, M., Michael, B. M., Sáez, A. J., Corona, M., Jiménez, C., Astibia, B., García, I., Rodríguez, E., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16801 · Cited by 168
Effect of the COVID-19 pandemic on cancer treatment and research
Saini, K. S., Heras, B. D. L., de Castro, J., Venkitaraman, R., Poelman, M., Srinivasan, G., Saini, M. L., Verma, S., Leone, M., Aftimos, P. G., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30123-x · Cited by 150
Self-citationWang, B., Oekelen, O. V., Mouhieddine, T. H., Valle, D. M. D., Richter, J. R., Cho, H. J., Richard, S., Chari, A., Gnjatic, S., Mérad, M., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00934-x · Cited by 147
Assaad, S., Avrillon, V., Fournier, M.-L., Mastroïanni, B., Russias, B., Swalduz, A., Cassier, P. A., Eberst, L., Steineur, M.-P., Kazes, M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.05.028 · Cited by 125
Zhang, H., Wang, L., Chen, Y., Wu, Q., Chen, G., Shen, X., Wang, Q., Yan, Y., Yu, Y., Zhong, Y., et al. (2020) · Cancer · doi:10.1002/cncr.33042 · Cited by 120
Cook, G. C., Ashcroft, A. J., Pratt, G., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16874 · Cited by 104
Clinical outcome of coronavirus disease 2019 in haemato‐oncology patients
Aries, J. A., DAVIES, J. K., Auer, R. L., Hallam, S. L., Montoto, S., Smith, M., Sevillano, B., Foggo, V., Wrench, B. P., Zegocki, K., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16852 · Cited by 98
Yarza, R., Bover, M., Paredes, D., López-López, F., Jara-Casas, D., Castelo-Loureiro, A., Baena, J., Mazarico, J. M., Folgueira, M. D., Meléndez-Carmona, M. Á., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.06.001 · Cited by 95
Rogado, J., Obispo, B., Pangua, C., et al. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02381-z · Cited by 92
Hultcrantz, M. L., Richter, J. R., Rosenbaum, C. A., Patel, D., Smith, E. L., Korde, N., Lu, S. X., Mailankody, S., Shah, U. A., Lesokhin, A. M., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0102 · Cited by 91
Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute
de Melo, A. C., Thuler, L. C. S., da Silva, J. L., de Albuquerque, L. Z., Pecego, A. C., Rodrigues, L. D. O. R., da Conceição, M. S., Garrido, M. M., Mendes, G. L. Q., Pereira, A. C. P. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241261 · Cited by 90
The natural history of symptomatic COVID-19 during the first wave in Catalonia
Burn, E., Tebé, C., Fernández‐Bertolín, S., Aragón, M., Recalde, M., Roel, E., Prats‐Uribe, A., Prieto‐Alhambra, D., & Duarte‐Salles, T. (2021) · Nature Communications · doi:10.1038/s41467-021-21100-y · Cited by 82
Stroppa, E. M., Toscani, I., Citterio, C., Anselmi, E., Zaffignani, E., Codeluppi, M., & Cavanna, L. (2020) · Future Oncology · doi:10.2217/fon-2020-0369 · Cited by 81
Martínez‐López, J., Mateos, M., Encinas, C., Sureda, A. M., Hernández‐Rivas, J., de la Guía, A. L., Conde, D., Krsnik, I., Prieto, E., Grau, R. R., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00372-5 · Cited by 81
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
Basse, C., Diakite, S., Servois, V., Frélaut, M., Noret, A., Bellesœur, A., Moreau, P., Massiani, M.-A., Bouyer, A.-S., Vuagnat, P., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa090 · Cited by 64
Russell, B. A., Moss, C. L., Papa, S., Irshad, S., Ross, P. J., Spicer, J. F., Kordasti, S. Y., Crawley, D., Wylie, H., Cahill, F., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01279 · Cited by 63
Pinato, D. J., Lee, A. J. X., Biello, F., Seguí, E., Carbó, A., Bruna, R., Bower, M., Rizzo, G., Benafif, S., Carmona, C., et al. (2020) · Cancers · doi:10.3390/cancers12071841 · Cited by 61
Kalinsky, K. M., Accordino, M. K., Hosi, K., Hawley, J. E., Trivedi, M. S., Crew, K. D., & Hershman, D. L. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05667-6 · Cited by 52
Cancer patients affected by COVID-19: Experience from Milan, Lombardy
Bogani, G., Ditto, A., Bosio, S., Brusadelli, C., & Raspagliesi, F. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.06.161 · Cited by 44
Joharatnam‐Hogan, N., Hochhauser, D., Shiu, K., Rush, H. L., Crolley, V. E., Wilson, W., Sharma, A., Muhammad, A., Anwar, M. N., Vasdev, N., et al. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920956803 · Cited by 37
Wu, Q., Chu, Q., Zhang, H., Yang, B., He, X., Zhong, Y., Yuan, X., Chua, M. L. K., & Xie, C. (2020) · 癌症：英文版 · doi:10.1002/cac2.12077 · Cited by 34
Call for ensuring cancer care continuity during COVID-19 pandemic
Tagliamento, M., Lambertini, M., Genova, C., Barisione, E., Maria, A. D., Grosso, M., Poggio, F. B., Vagge, S., Boccardo, F., Pronzato, P., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000783 · Cited by 32
Self-citationAngelis, V., Tippu, Z., Joshi, K., Reis, S., Gronthoud, F. A., Fribbens, C. V., Okines, A. F. C., Stanway, S. J., Cottier, E., McGrath, S., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.06.027 · Cited by 32
Coronavirus: older persons with cancer in Italy in the COVID-19 pandemic
Fratino, L., Procopio, G., Di Maio, M., Cinieri, S., Leo, S., & Beretta, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00648 · Cited by 28
Booth, S. W., Willan, J., Wong, H., Khan, D., Farnell, R., Hunter, A., Eyre, T. A., Katz, H., Dungarwalla, M., Chen, L., et al. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13469 · Cited by 26
Lattenist, R., Yıldız, H., Greef, J. D., Bailly, S., & Yombi, J. C. (2020) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-020-01318-4 · Cited by 19
Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patientsPreprint
González‐Cao, M., Antonazas-Basa, M., Puértolas, T., Muñoz‐Couselo, E., Manzano, J. L., Carrera, C., Márquez‐Rodas, I., Criado, P. L., Rodríguez-Moreno, J. F., García‐Castaño, A., et al. (2020) · medRxiv · doi:10.1101/2020.05.19.20106971 · Cited by 18
Systematic investigations of COVID-19 in 283 cancer patientsPreprint
Wang, J., Song, Q., Chen, Y., Wang, Z., Chu, Q., Gong, H., Cai, S., Dong, X., Xu, B., Hu, W., et al. (2020) · medRxiv · doi:10.1101/2020.04.28.20083246 · Cited by 13
Cited by
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Bange, E. M., Han, N. A., Wileyto, P., Kim, J. Y., Gouma, S., Robinson, J., Greenplate, A. R., Hwee, M. A., Porterfield, F., Owoyemi, O., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01386-7 · Cited by 519
Massarweh, A., Eliakim-Raz, N., Stemmer, A., Levy-Barda, A., Yust-Katz, S., Zer, A., Benouaich-Amiel, A., Ben-Zvi, H., Moskovits, N., Brenner, B., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.2155 · Cited by 265
Metadata
- Authors
- Saini, K. S., Tagliamento, M., Lambertini, M., McNally, R., Romano, M., Leone, M., Curigliano, G., & de Azambuja, E.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 139
- Pages
- 43-50
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W3082480386
- Cited by
- 331
- References
- 54
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
